Published in Int J Exp Pathol on February 01, 2012
Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats. Int J Exp Pathol (2012) 0.75
Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes. Int J Exp Pathol (2014) 0.75
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54
Extending healthy life span--from yeast to humans. Science (2010) 12.12
Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem (2004) 5.37
Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-B-cell leukemia. Science (1985) 4.29
Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev (2009) 3.22
Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J (2003) 2.94
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol (2001) 2.83
Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun (2000) 2.65
Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab (2003) 2.51
Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab (2008) 2.47
Comparative rates of synthesis of diphosphopyridine nucleotide by normal and tumour tissue from mouse mammary gland; studies with isolated nuclei. Biochem J (1956) 2.37
Enzymic synthesis of coenzyme I in relation to chemical control of cell growth. Nature (1958) 1.91
Metabolism of neoplastic tissue. VI. Assay of oxidized and reduced diphosphopyridine nucleotide in normal and neoplastic tissues. J Biol Chem (1955) 1.87
Functional aspects of protein mono-ADP-ribosylation. EMBO J (2003) 1.84
Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des (2009) 1.69
The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem (1981) 1.66
The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys (2009) 1.58
The pentose phosphate pathway of glucose metabolism. Measurement of the non-oxidative reactions of the cycle. Biochem J (1968) 1.54
Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in tumours. Biochem J (1957) 1.49
The pyridine nucleotide cycle. Nature (1966) 1.43
Synthesis of phosphoribosylpyrophosphate in mammalian cells. Adv Enzymol Relat Areas Mol Biol (1979) 1.18
Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells. Prog Nucleic Acid Res Mol Biol (2001) 1.04
The effect of cyclic nucleotides on purine biosynthesis and the induction of PRPP synthetase during lymphocyte activation. Cell (1974) 1.02
Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript. Biochim Biophys Acta (1989) 1.01
Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J (1992) 0.99
Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia (1988) 0.93
Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology (1988) 0.93
Concentration of phosphoribosyl pyrophosphate in the kidney during development and in experimental diabetic hypertrophy. Biochem J (1986) 0.91
Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int Suppl (1997) 0.90
Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia (1990) 0.90
Adrenal hypersensitivity precedes chronic hypercorticism in streptozotocin-induced diabetes mice. Endocrinology (2008) 0.90
Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia (1992) 0.89
The growth hormone-insulin-like growth factor axis in kidney. Am J Physiol (1989) 0.89
Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice. J Endocrinol (2002) 0.85
Regulating glucagon secretion: somatostatin in the spotlight. Diabetes (2009) 0.84
Evolving role of growth factors in the renal response to acute and chronic disease. J Am Soc Nephrol (1992) 0.83
Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors. J Dev Physiol (1989) 0.82
Abnormal regulation of adrenal function in rats with streptozotocin diabetes. Horm Metab Res (1977) 0.82
The role of growth hormone in the pathogenesis of diabetic kidney disease. Pediatr Endocrinol Rev (2004) 0.82
Phosphoribosyl pyrophosphate and phosphoribosyl pyrophosphate synthetase in rat mammary gland. Changes in the lactation cycle and effects of diabetes, insulin and phenazine methosulphate. Biochem J (1986) 0.82
The insulin family of peptides in early mammalian development. Curr Top Dev Biol (1990) 0.81
Influence of streptozotocin diabetes and insulin therapy on plasma corticosterone levels in male rats. Horm Metab Res (1983) 0.81
Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia (1989) 0.81
Autocrine and paracrine regulation of kidney epithelial cell growth. Annu Rev Physiol (1989) 0.80
The influence of streptozotocin diabetes on adrenal function in male rats. Horm Metab Res (1976) 0.80
Effect of insulin and phenazine methosulphate on pathways of glucose catabolism in the mammary gland of the rat. Nature (1959) 0.79
Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia (1991) 0.79
The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat. Biochem Med Metab Biol (1988) 0.79
Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes (1992) 0.78
Octreotide and diabetes: theoretical and experimental aspects. Metabolism (1992) 0.78
Activation of cow adrenal glucose 6-phosphate dehydrogenase by adrenocorticotropin. Biochemistry (1968) 0.78
The augmentation of pituitary adenylate cyclase-activating polypeptide (PACAP) in streptozotocin-induced diabetic rats. Peptides (1998) 0.78
Differential effects of somatostatin and angiopeptin on cell proliferation. Br J Pharmacol (1998) 0.77
Regulation of glucose metabolism in rat adrenal gland in alloxan-diabetes: the possible role of fructose 2,6-bisphosphate. Biochem Biophys Res Commun (1984) 0.77
Adrenocorticotropin-induced generation of 5'-phosphoribosylpyrophosphate and its relation to nucleotide synthesis in the adrenal cortex. Biochim Biophys Acta (1969) 0.76
ACTH stimulation of purine nucleotide biosynthesis in the adrenal cortex. ACTH stimulation of purine biosynthesis. Arch Biochem Biophys (1973) 0.76
Zona glomerulosa morphology and function in streptozotocin-induced diabetic rats. Endocrinology (1988) 0.76
Potential indications for octreotide in endocrinology. Metabolism (1992) 0.76
Regulation of RNA synthesis in corpora lutea nucleic by luteinizing hormone and derivatives. Biochim Biophys Acta (1976) 0.76
Endocrine applications of the somatostatin analogue octreotide (Sandostatin). Metabolism (1992) 0.76
Prevention and early detection of vascular complications of diabetes. BMJ (2006) 4.14
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology (2003) 3.59
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int (2008) 3.27
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol (2009) 2.79
Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise. J Physiol (2005) 2.75
Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab (2006) 2.52
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int (2004) 2.42
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology (2009) 2.39
Whey and casein labeled with L-[1-13C]leucine and muscle protein synthesis: effect of resistance exercise and protein ingestion. Am J Physiol Endocrinol Metab (2010) 1.82
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev (2004) 1.74
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology (2014) 1.73
Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes (2005) 1.71
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes (2002) 1.69
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J (2007) 1.63
Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am J Hypertens (2009) 1.61
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab (2006) 1.61
Adiponectin and lipoprotein particle size. Diabetes Care (2009) 1.60
Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes (2004) 1.59
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
Effects of five different alcoholic drinks on patients with Crohn's disease. Scand J Gastroenterol (2007) 1.51
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.49
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab (2007) 1.49
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart (2012) 1.47
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiology (2012) 1.44
Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer (2010) 1.40
Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials (2006) 1.38
Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol (2009) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients. Eur J Endocrinol (2006) 1.34
Assessment of early diabetic renal changes with hyperpolarized [1-(13) C]pyruvate. Diabetes Metab Res Rev (2013) 1.34
Cardiovascular disease and insulin-like growth factor I. Circulation (2002) 1.30
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2007) 1.27
Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes (2012) 1.27
The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol (2005) 1.23
Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol (2009) 1.18
Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2012) 1.17
Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology (2007) 1.16
Ghrelin and its relationship to growth hormones during normal pregnancy. Clin Endocrinol (Oxf) (2005) 1.15
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol (2010) 1.15
Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women. J Appl Physiol (1985) (2008) 1.13
Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab (2007) 1.12
Elevated levels of high-molecular-weight adiponectin in type 1 diabetes. J Clin Endocrinol Metab (2008) 1.12
Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol (2007) 1.12
Prognostic value of circulating chromogranin A levels in acute coronary syndromes. Eur Heart J (2008) 1.11
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes (2005) 1.10
Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care (2009) 1.10
Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med (2006) 1.09
Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.06
Complement activation and diabetic vascular complications. Clin Chim Acta (2005) 1.06
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology (2012) 1.05
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. Am Heart J (2010) 1.04
Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol (2006) 1.03
Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon. J Appl Physiol (1985) (2006) 1.01
Sex-discordant associations with adiponectin levels and lipid profiles in children. Diabetes (2006) 1.00
Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab (2008) 0.99
Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men. J Clin Endocrinol Metab (2002) 0.98
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens (2009) 0.98
Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clin Endocrinol (Oxf) (2006) 0.98
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol Dial Transplant (2005) 0.96
Adiponectin and risk of congestive heart failure. JAMA (2006) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovasc Diabetol (2011) 0.95
Relationship between periodontitis and diabetes: lessons from rodent studies. J Periodontol (2007) 0.95
Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2. Am J Physiol Renal Physiol (2006) 0.95
Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab (2003) 0.95
Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol (2006) 0.94
Left ventricular volume measurement in mice by conductance catheter: evaluation and optimization of calibration. Am J Physiol Heart Circ Physiol (2007) 0.94
Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes (2003) 0.93
Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol (2013) 0.93
GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients. Eur J Endocrinol (2010) 0.93
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf) (2007) 0.93
Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J Periodontol (2007) 0.93
No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle. Am J Physiol Endocrinol Metab (2005) 0.93
Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol (2003) 0.92
Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J Endocrinol (2006) 0.92
Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise. J Physiol (2008) 0.92
Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J Clin Endocrinol Metab (2004) 0.92
Simultaneous detection of porcine cytokines by multiplex analysis: development of magnetic bioplex assay. Vet Immunol Immunopathol (2009) 0.91
Pituitary-independent effect of octreotide on IGF1 generation. Eur J Endocrinol (2009) 0.91
Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant (2004) 0.91
Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2011) 0.91
Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki rats. J Periodontol (2006) 0.91
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol (2006) 0.91
Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis. J Appl Physiol (1985) (2006) 0.90
Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem (2002) 0.90
Body composition and common carotid artery remodeling in a healthy population. J Clin Endocrinol Metab (2008) 0.90
Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. Am J Cardiol (2011) 0.90
Adiponectin and cardiac geometry and function in elderly: results from two community-based cohort studies. Eur J Endocrinol (2009) 0.90
Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. J Invasive Cardiol (2009) 0.90
Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver. Comp Hepatol (2011) 0.90
Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab (2008) 0.89
Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol (1985) (2002) 0.89
Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model. Exp Diabetes Res (2012) 0.88
Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia (2013) 0.88
Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice. Eur J Heart Fail (2009) 0.88
Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion. Am J Physiol Gastrointest Liver Physiol (2012) 0.88